CEO of Guangzhou Xiangxue Pharmaceutical Life Science Center, Research Fellow of Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences, and National Key Program of Respiratory Diseases, Guangzhou, China Laboratory researcher. Dr. Li graduated from the Hunan Medical University (Xiangya) and received his Ph.D. from the University of Leicester College of Life Sciences. He spent 20 years in the UK doing antibody and T cell receptor research. His main research was focused on developing TCR-based immunotherapy. His works were published in Nature Biotechnology, Nature Medicine, JBC, Molecular Cancer Therapy, and so on.